Table 1.
Clinical characteristics of 74 COVID-19 patients in this study.
| Cases (%) | ||||
| Clinical characteristics | Total (n = 74) | ICU patient (n = 18) | Non-ICU patient (n = 56) | P |
| Age, median age, y | 47 (35–56) | 56 (47–68) | 43 (29–52) | <.001 |
| Age group, y | .031 | |||
| ≤18 | 2 (2.70) | 0 (0.00) | 2 (3.70) | |
| 19–40 | 25 (33.78) | 2 (11.11) | 23 (41.07) | |
| 41–65 | 35 (47.30) | 10 (55.56) | 25 (44.62) | |
| ≥66 | 12 (16.22) | 6 (33.33) | 6 (11.11) | |
| Sex | .059 | |||
| Male | 48 (64.86) | 15 (83.33) | 33 (59.93) | |
| Female | 26 (35.14) | 3 (16.67) | 23 (41.07) | |
| Exposure within 2 weeks | .469 | |||
| People from Wuhan | 36 (48.65) | 8 (44.44) | 28 (50.00) | |
| Contact with confirmed COVID-19 patients | 17 (22.97) | 6 (33.33) | 11 (19.64) | |
| No | 21 (28.38) | 4 (22.22) | 17 (30.36) | |
| Familial clustering | 21 (28.37) | 9 (50.00) | 12 (21.43) | .019 |
| Incubation period, median, days | 6 (4–10) | 9.5 (6–13) | 5 (4–9) | .013 |
| Common signs and symptoms | ||||
| Fever | 62 (83.78) | 15 (83.33) | 47 (83.93) | .952 |
| Cough | 55 (74.32) | 10 (55.56) | 45 (80.36) | .036 |
| Fatigue | 20 (27.03) | 4 (22.22) | 16 (28.57) | .598 |
| Myalgia | 11 (14.86) | 8 (44.44) | 3 (5.36) | <.001 |
| Difficulty breathing | 5 (6.76) | 5 (27.78) | 0 (0.00) | <.001 |
| Sore throat | 7 (9.46) | 1 (5.56) | 6 (10.71) | .515 |
| Expectoration | 20 (27.03) | 3 (16.67) | 17 (30.36) | .255 |
| Diarrhea | 5 (6.76) | 3 (16.67) | 2 (3.57) | .054 |
| Headache | 16 (21.62) | 2 (11.11) | 14 (25.00) | .213 |
| Hemoptysis | 1 (1.35) | 1 (5.56) | 0 (0.00) | .076 |
| Time from symptom onset to admission, median, days | 6 (4–10) | 9.5 (6–12) | 5 (4–8.25) | .013 |
| Signs upon admission | ||||
| Body temperature, °C | .124 | |||
| ≤37.2 | 43 (58.11) | 9 (50.00) | 34 (60.71) | |
| 37.3–38.0 | 19 (25.68) | 5 (27.78) | 14 (25.00) | |
| 38.1–39.0 | 10 (13.51) | 3 (16.67) | 7 (12.50) | |
| ≥39.1 | 2 (2.70) | 1 (5.56) | 1 (1.79) | |
| Respiratory rate, median, breath/min | 20 (19–20) | 19.5 (17.25–20) | 20 (19–20) | .874 |
| Pulse, median, beats/min | 85 (79–90) | 81.5 (76.5–89.5) | 85 (80–90.5) | .168 |
| Mean arterial pressure, median, mmHg | 92 (86.7–97.3) | 93.65 (87.8–100.9) | 92 (86.7–97) | .211 |
| Oxygen saturation (without oxygen therapy), % | 98 (95–98.8) | 95 (91–97.8) | 98 (96–99) | .009 |
| Length of hospital stay | 13 (10.3–16) | 16 (3–18.8) | 12 (9.8–15) | .013 |
| ≥2 underlying diseases | 17 (22.97) | 10 (55.56) | 7 (12.50) | <.001 |
| Hypertension | 21 (28.38) | 8 (44.44) | 13 (23.21) | .082 |
| Cardiovascular disease | 18 (24.32) | 4 (22.22) | 14 (25.00) | .811 |
| Diabetes | 9 (12.16) | 1 (5.56) | 8 (14.29) | .324 |
| Chronic obstructive pulmonary disease (COPD) | 2 (2.70) | 1 (5.56) | 1 (1.79) | .391 |
| Chronic kidney disease | 5 (6.76) | 1 (5.56) | 4 (7.14) | .815 |
| Chronic liver disease | 8 (10.81) | 1 (5.56) | 7 (12.50) | .409 |
| Sequela of stroke | 4 (5.41) | 3 (16.67) | 1 (1.79) | .015 |
| Malignant tumor | 1 (1.35) | 1 (5.56) | 0 (0.00) | .391 |